Dr. Lin became the new Director of Pediatric Nephrology in June 2011. While she was at University of Texas Southwestern Medical Center at Dallas for the last 10 years, she established herself as a physician scientist. Her ongoing research focuses on stem cell-based therapy for acute kidney injury and the mechanism of kidney tubular atrophy. Her research team applies state-of-the-art technology to study the pathogenesis of kidney disease. The ultimate goal of her basic science research is to develop new and more effective treatments for human kidney disease. Her research has been funded by the National Institutes of Health, the American Society of Nephrology, the American Heart Association, and March of Dimes Birth Defect Foundation.

Dr. Weng is an Assistant Professor of Pediatrics whose clinical and research interests focus on the genetics of congenital anomalies of the kidney and urinary tract (CAKUT). Specifically, Dr Weng is interested in the genetic determinants of vesicoureteral reflux (VUR), renal dysplasia/hypoplasia, and ureteropelvic junction obstruction (UPJO). She is also in charge of one of the largest registries/databases of patient and their families who have congenital anomalies of the kidney and urinary tract and other kidney diseases. Clinically, Dr. Weng has an active general pediatric nephrology practice and sees patients with a variety of pediatric renal disorders, including hypertension, electrolyte imbalances, and chronic kidney disease (including end stage renal disease and transplant patients).

Dr. Woroniecki is an Assistant Professor of Clinical Pediatrics and Medical Director of Pediatric Nephrology providing dedicated diagnostic and treatment services for children with kidney disorders, high blood pressure, and fluid and electrolytes imbalances. He has peer-accepted and published experience in those areas as well as in renal replacement therapies, transplantation, clinical trials, and pediatric hypertension. His efforts focus on End-stage Kidney Disease (ESKD), Chronic Kidney Disease, and Hypertension Programs, and administration and delivery of clinical services provided to the children by the multidisciplinary "kidney" team.

He received training in pediatric nephrology under the mentorship of Drs. Ira Greifer, Adrian Spitzer and Rick Kaskel. He was a recipient of a Career Development Award and a Principal Investigator on ancillary studies funded by NIDDK (National Institute of Diabetes and Digestive and Kidney Diseases), and received research support by Emerald Foundation. His current clinical research interests include: 1) molecular biomarkers of steroid resistance and progression in focal segmental glomerulosclerosis (FSGS) / nephrotic syndrome of childhood, and 2) ambulatory blood pressure monitoring (ABPM) in accelerated cardiovascular disease in children. Dr. Woroniecki mentored several Pediatric Nephrologists who are currently the recipients of both NIH and private foundation research fundings.